Tyler Welence

Tyler Welence is a medical writing and clinical development consultant at Intercept Pharmaceuticals since February 2023. Prior to this role, Tyler served as a Healthcare Investment Analyst at Tamarack Capital Management from April 2022 to February 2023, focusing on fundamental equity research in the biopharma and biotech sectors. Tyler has significant experience in medical writing, having held positions such as Senior Medical Writer at Exelixis and Medical Writer at both Rakuten Medical and Samorn Biosciences. Tyler began a career in clinical research as a Clinical Research Coordinator at UC San Diego Health, managing trial execution and patient interactions. Earlier experience includes roles in clinical trial assistance and an internship at Covanta Energy. Educational qualifications include a Master's Degree in Biomedical Clinical Research from UC San Diego and a Bachelor's degree in Public Health and Economics from McGill University.